BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 11, 2020
View Archived Issues
CanSino initiates phase I study of three-component DTcP vaccine candidate
Read More
BeiGene opens enrollment in phase I/II study of BGB-10188 for B-cell malignancies and solid tumors
Read More
Tonix and University of Alberta collaborate to develop novel COVID-19 vaccines
Read More
Winter depression-like behavior is regulated by seasonal changes in the NRF2 pathway
Read More
Targeted disruption of aquaporin-1 reduces intraocular pressure: potential gene therapy for glaucoma
Read More
Inhibition of P2X7 receptors improves synaptic and behavioral deficits in a Rett syndrome model
Read More
Oxidative DNA damage mediates colitis-associated colorectal cancer
Read More
New MVP against SVMP
Read More
Cynata receives ethics approval for MEND study of Cymerus MSCs in COVID-19
Read More
FDA approves IND for phase IIa study of opaganib for COVID-19
Read More
FDA clears IND application for phase II study of PLX cells in severe COVID-19
Read More
Health Canada grants approval for phase II study of LSALT peptide in patients with COVID-19
Read More
SNYE1 mutations associated with cerebellar ataxia and generalized dystonia
Read More
First-in-human results presented for SLC-0111 in advanced solid tumors
Read More
Cell competition links hyperinsulinemia to cancer
Read More
Boehringer Ingelheim identifies new NR2B receptor negative allosteric modulators
Read More
New phase I trial evaluates gene therapy to treat severe hemophilia A
Read More
New MAP3K5 inhibitors discovered at CJ HealthCare
Read More
Shanghai GeneChem synthesizes anti-CLDN128.2 antibodies
Read More
Shanghai Yichen Biomed patents EGFR-PD-1 bispecific antibodies
Read More
Roche describes new hepatitis B virus cccDNA formation inhibitors
Read More
Seattle Genetics initiates phase I study of SGN-TGT in advanced solid tumors and lymphomas
Read More
ZFYVE21 is a potential therapeutic target in cardiac allograft vasculopathy
Read More
FDA and China NMPA clear IND for Mabspace's humanized Claudin18.2 monoclonal antibody
Read More
SCN10A gene loss-of-function variant linked to neuropathy
Read More
FDA approves Retevmo for advanced RET-driven lung and thyroid cancers
Read More
Oncoinvent recruits for phase I study of Radspherin
Read More
FDA approves Lynparza with bevacizumab for HRD-positive advanced ovarian cancer
Read More
